Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 10, 2018

View Archived Issues

Glycosylation of allergens increases immune tolerance following immunization

Finding improves stem cell safety

GABA impairment not down to lack of receptors in ASD

Antigen loss, CAR gain can cause resistance to CAR T therapy

Thalidomide analogue DAID safely and effectively reduces ocular neovascularization in rats

Autologous fecal microbiota transplant restores intestinal microbiota after antibiotic treatment

Olfactory ensheathing cells can deliver therapeutic transgenes to gliomas through the nasal pathway

Merck & Co. presents phase I data for RSV MAb MK-1654

Nymox reports 78-month results from phase IIb prostate cancer study of fexapotide triflutate

M72/AS01 shows efficacy in reducing tuberculosis cases in previously infected HIV-negative adults

First patient enrolled in REIMAGINE phase IIa study of vafidemstat

AgeneBio obtains grants to support phase III study of AGB-101

Cancer drugs may be repurposed for inflammation

Forskolin-induced swelling of intestinal organoids classifies cystic fibrosis disease severity

Acceleron presents preliminary phase II data for ACE-083 in patients with CMT

First-in-human data presented for branaplam in SMA type 1

Neurocrine Biosciences and Jnana collaborate to treat CNS disorders

Newly developed IgA nephropathy murine model shows autoimmune character

Wave Life Sciences to design products for rare inherited eye diseases

Biohaven licenses therapeutic antibody from University of Connecticut

Advanced Proteome Therapeutics reports preclinical finding on antibody-amanitin conjugate

Lixte submits IND for phase Ib/II trial of LB-100 in MDS

Japanese JOINUS research program opens second public recruitment offering

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...